Effects of Aging and Diet on Cardioprotection and Cardiometabolic Risk Markers

Author:

Corina Andreea1,Abrudan Maria B.2ORCID,Nikolic Dragana3ORCID,Cӑtoi Adriana F.4,Chianetta Roberta3,Castellino Giuseppa3,Citarrella Roberto3ORCID,Stoian Anca P.5,Pérez-Martínez Pablo1,Rizzo Manfredi3ORCID

Affiliation:

1. Lipids and Atherosclerosis Research Unit, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, Spain

2. Department of Pharmaceutical Technology and Biopharmaceutics, "Iuliu Hațieganu", University of Medicine and Pharmacy, Faculty of Pharmacy, Cluj-Napoca, Romania

3. PROMISE Department, University of Palermo, Palermo, Italy

4. Pathophysiology Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

5. Department of Diabetes, Nutrition and Metabolic Diseases, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

Abstract

The prevalence of several diseases increases by age, including cardiovascular diseases, which are the leading cause of morbidity and mortality worldwide. Aging, as a complex process characterized by senescence, triggers various pathways, such as oxidative stress, systemic inflammation, metabolism dysfunction, telomere shortening, mitochondrial dysfunction and deregulated autophagy. A better understanding of the mechanisms underlying senescence may lead to the development of new therapeutic targets and strategies for age-related pathologies and extend the healthy lifespan. Modulating lifestyle risk factors and adopting healthy dietary patterns remain significant tools in delaying the aging process, decreasing age-associated comorbidities and mortality, increasing life expectancy and consequently, preventing the development of cardiovascular disease. Furthermore, such a strategy represents the most cost-effective approach, and the quality of life of the subjects may be significantly improved. An integrated, personalized approach targeting cardiometabolic aging and frailty is suggested in daily clinical practice. However, it should be initiated from an early age. Moreover, there is a need for further well designed and controlled studies in order to elucidate a link between the time of feeding, longevity and cardiovascular prevention. In the future, it is expected that the pharmacological treatment in cardioprotective management will be necessary, accompanied by equally important lifestyle interventions and adjunctive exercise.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. A pathological convergence theory for non‐communicable diseases;AGING MEDICINE;2023-11-05

2. Emerging role of α-Klotho in energy metabolism and cardiometabolic diseases;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2023-10

3. Association between the Mediterranean lifestyle, metabolic syndrome and mortality: a whole-country cohort in Spain;Cardiovascular Diabetology;2021-01-05

4. Nutraceuticals and Cardiovascular Disease;Nutraceuticals and Cardiovascular Disease;2021

5. Gut microbiota and aging;Critical Reviews in Food Science and Nutrition;2020-12-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3